Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
1-15 of 395
Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Project Oncology®Evidence-Based Treatment Decisions in Metastatic Triple-Negative Breast Cancer
Alexandria May, PharmD, BCPS
Neil M. Iyengar, MD
Interpreting and Applying cGVHD Clinical Trial Data
Project Oncology®Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP
Christopher Graham, MD
MCED Testing for Breast Cancer: Opportunities and Limitations
On the Frontlines of Metastatic Breast CancerMCED Testing for Breast Cancer: Opportunities and Limitations
Alexandria May, PharmD, BCPS
Marie Wood, MD
How Genetic Testing Guides Personalized mBC Care
On the Frontlines of Metastatic Breast CancerHow Genetic Testing Guides Personalized mBC Care
Alexandria May, PharmD, BCPS
Marie Wood, MD
Rethinking Frontline Care in HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerRethinking Frontline Care in HER2- Metastatic Breast Cancer
Alexandria May, PharmD, BCPS
Tiffany Traina, MD, FASCO
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
- advertisement
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Project Oncology®Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Urs Weber, MD
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Project Oncology®Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Urs Weber, MD
Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Project Oncology®Comprehensive Molecular Testing in ALK+ Non-Small Cell Lung Cancer
Urs Weber, MD
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Project Oncology®Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Urs Weber, MD
Rising Colorectal Cancer in Young Adults: Implications for Screening
Clinician's RoundtableRising Colorectal Cancer in Young Adults: Implications for Screening
Christopher Cann, MD
- advertisement
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Project Oncology®Post-BCMA Treatment Selection in R/R Multiple Myeloma
Steve Jackson, PharmD
Nisha Joseph, MD
Case: Implementing ADT Intensification in mHSPC
MinuteCE®Case: Implementing ADT Intensification in mHSPC
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
